MarketInOut Stock Screener Log In | Sign Up
 

EssilorLuxottica S.A.

OTC • Healthcare • Medical Instruments & Supplies • Quote as of 10/23/2026 15:52
EssilorLuxottica S.A. stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeOTC
Market Capitalization76,736 mln
Float306 mln
Earnings Date02/11/2027

EPS

6.24
Stretched

P / E

31.85
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.65
Likely reliable

Relative Strength

95 / 100
Top performer

Debt / Equity

0.39
Low leverage

Business Description

EssilorLuxottica is a Paris-based company founded in 1849 that makes and sells a wide range of vision products, including prescription lenses, eyeglass frames, sunglasses, and contact lenses, through well-known brands such as Ray-Ban, Oakley, Transitions, and Varilux. The company also develops advanced diagnostic and imaging tools used by eye care professionals to assess and treat vision conditions. Its products reach customers worldwide through independent opticians, retail chains, and online platforms across every major region.

Key Fundamentals

EPS6.24
P/E31.85
ROE6.45
RPS71.24
ROIC4.51
ROA3.92
Interest Cover10.20
EBITDA, mln8,104
EV / EBITDA11.89
EV / EBIT21.63
Revenue, mln34,157
EV / Revenue2.82

Quote Details

Last 198.6900
Change 0.19 (0.1%)
Open 205.3050
Volume 1,103
Turnover 219,155
Average Volume 6,750.67

Financial Ratios

Pre-Tax Profit Margin12
Leverage Ratio1.66
Current Ratio0.89
Price / Book1.75
Price / Cash Flow12.48
Price / Free Cash Flow17.21
Debt / Equity0.39
Price / Sales2.43
PEG Ratio1.69

Financial Strength

Altman Z-Score2.63
Piotroski F-Score 6 / 9
Beneish M-Score-2.65
Price to Intrinsic Value0.92
Price to Lynch Fair Value1.82
Shiller PE Ratio36.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 16.94% 95 / 100   
1 Month 22.83% 95 / 100   
2 Months 4.33% 69 / 100   
6 Months -9.99% 46 / 100   
1 Year -46.01% 20 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog